Logotype for Navamedic

Navamedic (NAVA) investor relations material

Navamedic Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Navamedic
Q2 2025 earnings summary14 Aug, 2025

Executive summary

  • Achieved stable growth in H1 2025, with strategic initiatives and acquisitions supporting expansion.

  • Revenue for H1 2025 was 269.3 MNOK, down from 277.2 MNOK; excluding a 22.7 MNOK license fee in 2024, revenue grew 5.8% YoY.

  • Closed acquisition of dne pharma, strengthening position in addiction and pain therapies.

  • First approval of OraFID® as primary package for Flexilev®, with commercial launch planned for Q4 2025.

  • EBITDA for H1 2025 was 22.9 MNOK, up 24.5% YoY when excluding the 2024 license fee.

Financial highlights

  • Q2 2025 revenue was 137.3 MNOK, down 12.2% YoY; up 2.8% YoY when adjusted for a prior license fee.

  • Gross margin in H1 2025 was 39.0% (42.9% in H1 2024; 37.8% excluding license fee).

  • Q2 EBITDA was 10.1 MNOK (7.4% margin); H1 EBITDA at 22.9 MNOK (8.5% margin), both above 2024 when excluding one-time items.

  • H1 2025 net loss was 9.0 MNOK, compared to a net profit of 17.9 MNOK in H1 2024 (minus 5.7 MNOK excluding license fee).

  • Cash and cash equivalents stood at 42.7 MNOK at the end of H1 2025, up 2.3 MNOK from previous quarter.

Outlook and guidance

  • Strategic levers in place for continued growth, including portfolio expansion, licensing, and M&A.

  • Anticipated commercial launch of Flexilev® in OraFID® across the Nordics in Q4 2025.

  • Ambition to reach NOK 1 billion in revenue through profitable, sustainable growth is reiterated.

  • Board expects positive development to continue in H2 2025.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Navamedic earnings date

Logotype for Navamedic
Q3 202528 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Navamedic earnings date

Logotype for Navamedic
Q3 202528 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Navamedic ASA is a Norwegian pharmaceutical company focused on developing, producing, marketing, and distributing a range of healthcare products. Its portfolio includes both prescription and non-prescription pharmaceuticals, medical nutrition products, medical devices, and consumer health items such as food supplements and cosmetics. The company primarily serves hospitals, pharmacies, and patients across the Nordic countries, Benelux, and the Baltics, with additional presence in the UK and other European markets. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage